Diaceutics (LON:DXRX) Shares Down 0.6% – Time to Sell?

Diaceutics PLC (LON:DXRX)’s share price traded down 0.6% during mid-day trading on Thursday . The company traded as low as GBX 165 and last traded at GBX 166.50. 683,387 shares were traded during mid-day trading, an increase of 197% from the average session volume of 229,901 shares. The stock had previously closed at GBX 167.50.

Wall Street Analysts Forecast Growth

Separately, Shore Capital Group increased their price objective on shares of Diaceutics from GBX 180 to GBX 215 and gave the stock a “buy” rating in a research report on Thursday, January 15th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of GBX 193.33.

Diaceutics Stock Down 0.6%

The business’s fifty day moving average is GBX 147.80 and its two-hundred day moving average is GBX 150.09. The stock has a market cap of £140.90 million, a price-to-earnings ratio of -92.50 and a beta of 0.58. The company has a quick ratio of 9.92, a current ratio of 4.85 and a debt-to-equity ratio of 0.39.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.